Enteric fever, primarily caused by Salmonella Typhi and Salmonella Paratyphi, is a systemic infection that continues to pose significant health challenges, particularly in endemic regions. Early diagnosis and effective treatment are crucial to control the spread and reduce morbidity and mortality associated with this disease.
The gold standard for diagnosing enteric fever is blood culture, which has a sensitivity of 40-60% in the first week of illness. However, it requires technical expertise and is time-consuming. Newer molecular techniques such as Polymerase Chain Reaction (PCR) and Nucleic Acid Amplification Tests (NAATs) offer higher sensitivity and specificity, and faster results. Serological tests like Widal Test are commonly used in resource-poor settings, but they have significant limitations in terms of sensitivity and specificity.
Antibiotic therapy is the mainstay of treatment for enteric fever. Choice of antibiotic should be guided by local susceptibility patterns as multi-drug resistant strains are increasingly common. Fluoroquinolones were once the drug of choice, but resistance has led to the use of third-generation cephalosporins like ceftriaxone and azithromycin. Vaccination is an effective preventive measure, especially for travelers to endemic areas and people living in high-risk regions.
Despite advances in diagnostic techniques and treatment options, challenges remain in controlling enteric fever. These include the emergence of antibiotic-resistant strains, limited access to diagnostic facilities in resource-poor settings, and lack of a highly effective vaccine. Continued research is needed to develop more effective vaccines and novel diagnostic tools. Public health measures such as improving sanitation and access to clean water are also crucial in controlling the spread of enteric fever.
Enteric fever remains a significant global health issue. While strides have been made in diagnosis and treatment, challenges persist. It is essential for healthcare professionals to stay abreast of current diagnostic methods and treatment strategies to effectively manage this disease and reduce its global impact.
1.
For MDS-Related Anemia, Telomerase Inhibitor Approved.
2.
Efficacy and safety of intravenous chemotherapy in children with intraocular retinoblastoma
3.
Admissions, medical schools, costs, and eligibility requirements information for FNB Onco-Anesthesia.
4.
Treating Depression: Crucial for Recovery From Fibromyalgia
5.
In postmenopausal women with hormone receptor-positive tumors, obesity increases the risk of breast cancer recurrence.
1.
Empowering Oncology with Data: Cloud Security, Real-World Evidence, and Clinical Insights
2.
Immune Regulation of Blood Cell Development
3.
Exploring the Effects of Radiation Therapy on Cystitis: A Journey to Better Health
4.
Transformative Frameworks in Oncology for Better Care
5.
Liposomal Doxorubicin and Mitomycin in Modern Cancer Treatment
1.
International Conference on Oncology, Cancer Prevention and Public Health
2.
International Conference on Cancer Nursing and Rehabilitation Strategies
3.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
4.
International Conference on Innovations in Critical Care for Oncology and Cardiology
5.
International Symposium on Oncology, Cardiology and Critical Care Innovations
1.
Targeting Oncologic Drivers: A New Approach to Lung Cancer Treatment
2.
Newer Immunotherapies for Myeloma- A Comprehensive Overview
3.
Understanding the causes of anemia in adults beyond nutritional deficiencies
4.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part III
5.
Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation